表紙
市場調査レポート

医薬品原薬(API)の米国市場

Active Pharmaceutical Ingredients (API) Market in the US 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 324081
出版日 ページ情報 英文 65 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.50円で換算しております。
Back to Top
医薬品原薬(API)の米国市場 Active Pharmaceutical Ingredients (API) Market in the US 2015-2019
出版日: 2015年02月04日 ページ情報: 英文 65 Pages
概要

医薬品原薬(API)は、医薬品の製造に使用される薬理効果を有する活性物質です。米国におけるAPI市場は、2014年から2019年の間、7.01%の複合年間成長率(CAGR)で拡大することが予測されています。

当レポートでは、米国における医薬品原薬(API)市場の現況と今後の成長見通しを調査しており、製造工程別および治療領域別の市場規模とその予測、市場の成長因子と課題、主要企業のプロファイルなどを提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要

第7章 米国のAPI市場

  • 市場規模と予測
  • 輸出と国内消費
  • ファイブフォース分析

第8章 製造工程タイプ別の市場区分

第9章 治療領域別の市場区分

  • 抗感染症
  • 心血管および造血系
  • 中枢神経系
  • 胃腸および肝胆道系
  • 呼吸器系
  • 腫瘍

第10章 購入基準

第11章 市場成長因子

第12章 成長因子とその影響

第13章 市場の課題

第14章 成長因子と課題の影響

第15章 市場動向

第16章 動向とその影響

第17章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
  • 主要ベンダーのランキング
  • その他の有力ベンダー

第18章 主要ベンダーの分析

  • Aurobindo Pharma
  • Cipla
  • Dr. Reddy's Laboratories

第19章 関連レポート

目次
Product Code: IRTNTR5191

About API

Active pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology and for treatment of conditions such as respiratory disorders and rheumatoid arthritis.

TechNavio's analysts forecast the API market in the US to grow at a CAGR of 7.01 percent over the period 2014-2019.

Covered in this Report

The report covers the present scenario and the growth prospects of the API market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. It provides the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The market segmentation is carried out on the basis of: type of production process (synthetic production process and biotechnology-based production process), type of product (conventional API and high-potency API), and type of players (captive and merchant).

The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the API Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Key Vendors

  • Abbott Laboratories
  • Aurobindo Pharma
  • Mylan
  • Teva Pharmaceutical Industries

Other Prominent Vendors

  • Albemarle
  • Aptuit
  • BASF
  • Biocon
  • Boehringer Ingelheim
  • Cambrex
  • Cipla
  • Dr. Reddy's Laboratories
  • Hospira
  • Lonza Group
  • Novartis
  • Pfizer
  • Sigma-Aldrich
  • Sun Pharmaceutical Industries

Market Driver

  • Strong Preference for Generic Drugs
  • For a full, detailed list, view our report

Market Challenge

  • Decrease in R&D Spending
  • For a full, detailed list, view our report

Market Trend

  • Strong Focus on High-potency API
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview

07. API Market in the US

  • 07.1. Market Size and Forecast
  • 07.2. Five Forces Analysis

08. Market Segmentation by Type of Production Process

09. Market Segmentation by Type of Product

10. Market Segmentation by Type of Players

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
  • 18.2. Key Vendors 2014
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Abbott Laboratories Inc.
    • 19.1.1. Key Facts
    • 19.1.2. Business Description
    • 19.1.3. Business Segmentation
    • 19.1.4. Business Strategy
    • 19.1.5. Revenue by Business Segmentation
    • 19.1.6. Revenue Comparison 2011 and 2012
    • 19.1.7. Revenue by Geographical Segmentation
    • 19.1.8. Key Information
    • 19.1.9. SWOT Analysis
  • 19.2. Aurobindo Pharma
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. Business Segmentation
    • 19.2.4. Geographical Segmentation by Revenue 2014
    • 19.2.5. Business Strategy
    • 19.2.6. Recent Developments
    • 19.2.7. SWOT Analysis
  • 19.3. Mylan
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Business Segmentation by Revenue 2013
    • 19.3.4. Business Segmentation by Revenue 2011-2013
    • 19.3.5. Geographical Segmentation by Revenue 2013
    • 19.3.6. Business Strategy
    • 19.3.7. Recent Developments
    • 19.3.8. SWOT Analysis
  • 19.4. Teva Pharmaceutical Industries
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. Business Segmentation
    • 19.4.4. Business Segmentation by Revenue 2013
    • 19.4.5. Business Segmentation by Revenue 2012 and 2013
    • 19.4.6. Sales by Geography
    • 19.4.7. Business Strategy
    • 19.4.8. Key Developments
    • 19.4.9. SWOT Analysis

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Segmentation of the API Market in US
  • Exhibit 3: Segmentation of the API Market in US by Type of Production Process
  • Exhibit 4: Segmentation of the API Market in US by Type of Product
  • Exhibit 5: Segmentation of the API Market in US by Type of Players
  • Exhibit 6: API Market in the US 2014-2019 (US$ billion)
  • Exhibit 7: Segmentation of API Market in US by Technology 2014
  • Exhibit 8: Segmentation of the API Market in US by Type of Product 2014
  • Exhibit 9: Segmentation of the API Market in US by Type of Players 2014
  • Exhibit 10: Small Molecule Drugs: Patent Expiry during 2013-2016
  • Exhibit 11: Abbott Laboratories Inc.: Business Segmentation
  • Exhibit 12: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012
  • Exhibit 13: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 (US$ million)
  • Exhibit 14: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012
  • Exhibit 15: Aurobindo Pharma: Business Segmentation
  • Exhibit 16: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
  • Exhibit 17: Active Pharmaceutical Ingredients (API) Market in the US: Business Segmentation by Revenue 2013
  • Exhibit 18: Active Pharmaceutical Ingredients (API) Market in the US: Business Segmentation by Revenue 2011-2013 (US$ billion)
  • Exhibit 19: Active Pharmaceutical Ingredients (API) Market in the US: Geographical Segmentation by Revenue 2013
  • Exhibit 20: Teva Pharmaceutical Industries: Business Segmentation
  • Exhibit 21: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
  • Exhibit 22: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 23: Teva Pharmaceutical Industries: Sales by Geography 2013
Back to Top